Li Y-R*, Fang Y*, Niu S*, Zhu Y*, Chen Y, Lyu Z, Zhu E, Tian Y, Huang J, Rezek V, Kitchen S, Hsiai T, Zhou JJ, Wang P, Chai-Ho W, Park S, Seet CS, Oliai C, and Yang L. (*Co-first authors). Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies. Nat Commun. 2025 Feb 1; 16(1):1248. doi: 10.1038/s41467-025-56270-6. [Nature Communications PDF][UCLA BSCRC PDF]